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Objective: Recently, the relationship between immunoglobulin (Ig)G4 and idiopathic sclerosing lesions has attracted
much attention. IgG4-related disease was first described with regard to the pancreas (autoimmune pancreatitis), and has
been expanded to various organ systems. We previously reported that inflammatory abdominal aortic aneurysm (IAAA)
could be one of the manifestations of IgG4-related disease. In this study, we tried to elucidate the clinical characteristics
of IgG4-related IAAA.
Methods: This study consisted of 23 cases of IAAA and 40 cases of atherosclerotic abdominal aortic aneurysm (AAA).
Clinical presentation, laboratory findings, and pathological features were examined. Aneurysms of 13 cases histologically
corresponded to IgG4-related IAAA.
Results: Those cases accounted for 5% of all surgical AAAs, and 57% of IAAAs. Compared to non-IgG4-related IAAA,
IgG4-related cases were characterized by less frequent association with abdominal or back pain. Serum IgG4 concentra-
tions were significantly elevated in IgG4-related cases. Interestingly, patients with IgG4-related IAAA frequently showed
an allergic constitution, such as drug allergy, autoimmune diseases, high serum IgE concentrations, and a high titer of
antinuclear antibody. Pathologically, IgG4-related cases were characterized by more significant thickening of the
adventitia and more numerous IgG4-positive plasma cell infiltrations. Three non-IgG4-related cases showed aneurysmal
rupture at the time of first presentation, whereas no IgG4-related cases showed rupture.
Conclusion: Recognizing a new disease entity of IgG4-related IAAA seems important because this was clinically and
pathologically different from conventional aAAA and non-IgG4-related IAAA. (J Vasc Surg 2009;49:1264-71.)
Clinical Relevance: IgG4-related disease was determined by irregular fibrous tissue proliferation with numerous
infiltrations of IgG4-positive plasma cells and concentration of serum IgG4, and clinically characterized steroid
sensitivity. We examined 23 cases of IAAA and 40 cases of aAAA, and revealed about half cases of IAAA was linked to the
peri-aortic counterpart of IgG4-related disease. IgG4-related IAAA was clinicopathologically different from conven-
tional aAAA and non IgG4-related IAAA, that is, IgG4-related IAAA was particularly characterized by frequency of
complication of autoimmune diseases, low incidence of rupture, and high serum IgE concentration.Some abdominal aortic aneurysms (AAA) are charac-
terized by diffuse thickness of the aneurysmal wall and
extensive fibrous adhesion to adjoining tissues. In 1972,
Walker et al first used the term inflammatory AAA (IAAA)
to describe such aneurysms.1 It was reported that IAAA is
2-10% of all AAA.1,2 In comparison to atherosclerotic AAA
(aAAA), IAAA has different clinical characteristics, such as
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1264younger age of the patients, symptoms such as backache,
low-grade fever, or weight loss, and a larger diameter.1-4
Controversies exist regarding the cause and pathogen-
esis of IAAA. Some reports described that atherosclerotic
aneurysm formation is the preceding phenomena, and that
the inflammatory response is a secondary change;5 that is,
IAAA is the extreme end of an inflammatory process.6,7
Other reports suggested the possible involvement of auto-
immune reaction in the pathogenesis of IAAA.8-10 Patients
with IAAA sometimes show serological autoimmune ab-
normalities such as positive for auto-antibodies, or are
associated with systemic autoimmune diseases.10 In addi-
tion, several studies have suggested that IAAA may be due
to an exaggerated immune response to infectious agents.11,12
IAAA is now considered to be a heterogeneous disease
entity.
Recently, a close relationship between immunoglobu-
lin G4 (IgG4) and idiopathic sclerosing lesions has been
suggested. IgG4-related sclerosing lesion, which is also
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reported with regard to autoimmune pancreatitis (scleros-
ing pancreatitis).13 This disease entity has been expanded
to various organs, such as the bile duct,14 salivary gland,15
retroperitoneum,16,17 and lung.18 Irrespective of the organ
of origin, IgG4-SD show common clinicopathologic fea-
tures. Clinical characteristics of IgG4-SD are its frequent
occurrence in adult male patients, elevation of serum IgG4
levels, and steroid sensitivity.19,20 IgG4-SD is pathologi-
cally characterized by diffuse lymphoplasmacytic infiltra-
tion, irregular fibrosis, and obliterative phlebitis. Immuno-
staining of IgG4 reveals diffuse infiltration of IgG4-positive
plasma cells.14-18 In addition, some patients have multiple
lesions in different organs at the same time or during
follow-up;19-21 that is, IgG4-SD is a systemic disorder, and
each lesion is estimated as one of the manifestations of this
systemic disorder.21
Recently, we pathologically examined IAAA from the
viewpoint of IgG4.22 We reported that some IAAA are
IgG4-SD;22 that is, IAAA could be classified into IgG4-
related and non-related cases. IgG4-related cases showed
elevated levels of serum IgG4 and diffuse infiltration of
IgG4-positive plasma cells in the aneurysmal adventitia.22
In contrast, non-IgG4-related cases had a more intense
atherosclerotic reaction than IgG4-related cases; however,
it has not been revealed whether any clinical differences
exist between IgG4-related (IgG4-IAAA) and non-related
IAAA (non-IgG4-IAAA). In particular, it seems important
to know the steroid sensitivity or incidences of the rupture
of IgG4-related and non-related cases, because they influ-
ence our therapeutic strategies for patients with IAAA.
In this study, we examined clinical and serological
differences among aAAA, IgG4-IAAA, and non-IgG4-
IAAA. The goal of this study is to reveal the clinical char-
acteristics of IgG4-IAAA.
MATERIALS AND METHODS
The present study is approved by the human investiga-
tion review Committee of the University of Kanazawa
(NO.468) and Kanazawa Medical Center (NO.248) and
conforms to the principles outlined in the Declaration of
Helsinki.
Case selection. During 1996 to 2007, we surgically
treated 252 cases of AAA in our hospitals. In this study, we
examined all cases of IAAA (23 cases) based on the patho-
logical definition described below. From 2004 to 2007, 40
cases of aAAA were randomly selected as a disease control.
Patients with suppurative infection (fungus and bacteria),
vasculitis, or malignant tumors were excluded from this
study.
Diagnosis of IAAA. Aneurysmal walls of all cases
were histologically examined, and we diagnosed IAAA
based on pathological findings (Fig 1). The explanted
aneurysm wall in cases of IAAA showed diffuse fibrous
thickening of the adventitia (more than 4 mm) with abun-
dant lymphoplasmacytic infiltration. Pathologically diag-
nosed IAAA included all cases of clinically suspected IAAA
(by pre- and/or intraoperative findings). Atheromatousdegeneration and calcification were also observed in the
intima, although fibrous and inflammatory changes in the
adventitia were more conspicuous. The diagnosis of IgG4-
IAAA was based on histologic findings of numerous IgG4
positive plasma cells (60/high-power field [hpf] and more
than 60% of the IgG4/IgG-positive cell ratio) in the ad-
ventitia (Fig 2). The entire analysis of histological findings
was performed by two pathologists (S.K. and Y.Z.) who
were blinded to the clinical features of the sample.
Risk factors and associated conditions. We exam-
ined the association with risk factors for AAA, such as a
smoking habit, hypertension, diabetes, and hyperlipidemia
using the preoperative clinical records of each patient ret-
rospectively. A history of ischemic heart disease and auto-
immune disorders was also examined. In addition, we
examined whether patients had a history of allergic disor-
ders, such as bronchial asthma and drug allergy, because
recently the association between IgG4-SD and allergic
reaction has been suggested.23
Laboratory examination. Within 1 month before
surgery, all patients underwent routine laboratory evalua-
tion, including white blood cell count (WBC), C-reactive
protein (CRP), serum total protein, serum albumin, total
choresterol, high-density lipoprotein (HDL) choresterol,
low-density lipoprotein (LDL) cholesterol, and triglycer-
ide. Preoperative serum samples were available for 6 cases of
Fig 1. Macroscopic appearance of the abdominal aortic wall of
IgG4-related inflammatory abdominal aortic aneurysm (IAAA)
shows thickened fibrotic adventitia and periaortic tissues (white
arrow). Scale bar:5 mm.IgG4-IAAA, 4 cases of non-IgG4-IAAA, and all cases of
ages
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IgE, and antinuclear antibodies (ANA), and C3 and C4
complement fractures. All cases were selorogically negative
for syphilis.
Histologic examination. Surgically resected speci-
mens were fixed in neutral formalin and embedded in
paraffin. Sections were stained with hematoxylin and eosin
(H&E) and elastica-van Gieson (EvG), and the rest were
used for immunohistochemistry. Immunostaining of IgG
and IgG4 was performed by an autostainer (HX System
Benchmark, VentanaMedical Systems, Tucson, Ariz) as per
the manufacturer’s instructions. Primary antibodies used
were a rabbit monoclonal antibody against human IgG
(Dako Cytomation, Glostrup, Denmark) and a mouse
monoclonal antibody for human IgG4 (ZYMED Labora-
tory, Inc, San Francisco, Calif). Sections were pretreated
with proteinase. Negative controls were evaluated by sub-
stituting the primary antibody with similarly diluted non-
immunized mouse serum. IgG- and IgG4-positive plasma
cells were counted in 5 different hpf (10 eyepiece and 40
 lens) in more prominently inflamed areas in the aneu-
rysm wall, and the numbers were compared. The ratio of
IgG4-positive cells to IgG-positive cells was also calculated
for each case. The intimal thickness (from the surface of
atherosclerotic palque to inner elastic fiber of the media)
and adventitial thickness (from outer elastic fiber of the
media to the lowest part of the adventitia) were calculated
on EvG-stained sections using a microscopic measure. In ad-
dition, we also examined whether the following seven
histological features were evident: neutrophil infiltration
Fig 2. Histopathologic features of IgG4-related inflam
shows fibrous adventitial thickening with inflammatory c
lower, elastica van Gieson [EvG]; both images, 20, in
IgG and IgG4 plasma cells in the adventitia (right im(more than 10 per hpf), eosinophilic infiltration (more than5 per hpf), plasma cell infiltration (more than 10 per hpf),
lymph follicle with germinal center, obliterative phlebitis,
granuloma formation, and perinueral inflammatory cell
infiltration.
Intraoperative findings and postoperative outcome.
We examined intraoperative findings based on the basis of a
retrospective review of the operative notes of each surgeon.
Complications within 30 days of surgery and long-term
follow-up data were taken from the clinical records of each
patient.
Statistics. Statistical analyses were performed using
Fisher’s test, the 2 test, when appropriate with the Yates
correction, and the Mann-Whitney rank sum test for un-
paired nonparametric data. Values of P  .05 were re-
garded as significant.
RESULTS
Clinical presentation. For 12 years (1996 to 2007),
252 cases of AAA were surgically treated in our hospitals.
Histologic examination revealed that 23 cases (9% of 252
cases) corresponded to IAAA, and the remaining 229 cases
were aAAA. Among 23 cases of IAAA, 13 cases histologi-
cally showed numerous IgG4-positive plasma cell infiltra-
tions in the aneurysmal adventitia. Those cases were exam-
ined as IgG4-IAAA in this study. In contrast, the remaining
10 cases of IAAA had a few IgG4-positive plasma cells, and
corresponded to non-IgG4-IAAA. Incidences of IgG4-
IAAA and non-IgG4-IAAA were 5% and 4% of surgically
treated AAA cases, respectively. IgG4-IAAA was 57% of
ry abdominal aortic aneurysm (IAAA). Aneurysmal wall
ltration (left upper, hematoxylin and eosin [H&E]; left
ost the same field). Immunostainings reveal numerous
, 200, in almost the same fields).mato
ell infi
almIAAA.
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Patients with IAAA were significantly younger than those
with aAAA. All patients underwent radiological examina-
tion by computed tomography (CT). Preoperatively, a CT
scan revealed wall thickening or periaortic mass formation
for the radiologic diagnosis of IAAA, in three cases of
IgG4-IAAA (23%) and four cases of non-IgG4-IAAA
(40%). Aneurysmal diameters were not different betweeen
IAAA and aAAA. Small aneurysms (about 30 mm in diam-
eter) were resected due to their saccular form, and were
detected in one case of IgG4-IAAA and one case of non-
IgG4-IAAA. Several cases of IgG4-IAAA showed a trend
toward irregular thickening of the abdominal wall by ret-
rospective radiological re-examination. Iliac arteries were
involved in 6 patients with aAAA (15%), 1 patient with
IgG4-IAAA (8%), and 1 patient with non-IgG4-IAAA
(10%).
Twelve patients with IAAA (52%) presented with con-
stitutional symptoms such as low-grade fever (37-37.5°C)
dull abdominal or back pain, fatigue, anorexia, and weight
loss over several months, whereas the remaining cases were
incidentally found to have AAA during routine medical
examinations or work-ups for other diseases. Abdominal or
back pain was more commonly observed in patients with
non-IgG4-IAAA cases compared to IgG4-IAAA cases (50%
vs 8%, P  .025). Aneurysmal rupture was observed in 3
Table I. Clinical characteristics of patients with atheroscle
AAA
Atherosclerotic Inflamm
(n  40) (n  2
Age (years) 75 (56-87) 69 (59-8
Gender (male/female) 32/8 20/3
Aneurysmal diameter (mm) 56 (27-100) 55 (28-1
Symptoms
Low grade fever 3 (8%) 9 (39%
Abdominal or back pain 5 (13%) 6 (26%
Rupture 3 (8%) 3 (13%
Death immediately after surgery 0 2 (1%)
AAA, Abdominal aortic aneurysm.
Table II. Risk factors and associated conditions of abdom
AAA
Atherosclerotic Inflammatory
(n  40) (n  23)
Smoking habit 28 (70%) 14 (61%)
Hypertension 15 (38%) 6 (26%)
Ischemic heart diseases 14 (35%) 8 (35%)
Diabetes 10 (25%) 2 (9%)
Hyperlipidemia 7 (18%) 4 (17%)
Autoimmune diseases 5 (13%) 8 (35%)
Drug allergy 5 (13%) 6 (26%)
Bronchial asthma 3 (8%) 5 (21%)
AAA, Abdominal aortic aneurysm.patients with IAAA. Interestingly, all were non-IgG4-IAAA cases. Aneurysmal rupture was more common in
non-IgG4-IAAA than IgG4-IAAA (30% vs 0%, P  .038).
Risk factors and associated conditions. Incidences
of risk factors and associated conditions of AAA are shown
in Table II. Incidences of a smoking habit, hypertension,
ischemic heart diseases, hyperlipidemia, and allergic disor-
ders were not different between patients with aAAA and
IAAA. All patients with a medical history of hyperlipidemia
were treated with statins. Comparing IgG4-IAAA and non-
IgG4-IAAA, a smoking habit, hypertension, ischemic heart
diseases, and diabetes were slightly less common in IgG4-
IAAA. In contrast, allergic and autoimmune diseases were
frequently observed in IgG4-IAAA. Five patients with
IgG4-IAAA had drug allergies (2 patients, cefazolin so-
dium; 2 patients, xylocaine; 1 patient, contrast medium
iopronide). Four patients had a history of bronchial asthma.
In addition, 7 patients with IgG4-IAAA had autoimmune
diseases (3 patients, rhumatoid arthritis; 2 patients, idio-
pathic thrombocytopenic purpura; 1 patient, Sjögren’s dis-
ease; antiphospholipid antibody syndrome) with a signifi-
cantly higher incidence. In patients with non-IgG4-IAAA,
1 patient was complicated with chronic renal failure and 1
patient with alcoholic liver injury, while these injuries were
not detected in patients with IgG4-IAAA, no patients
examined in this study had any history of IgG4-SD at other
sites. No patients were treated with corticosteroids before
or inflammatory abdominal aneurysm
P value
Inflammatory AAA
P value
IgG4-related Non-IgG4-related
(n  13) (n  10)
.005 70 (59-76) 69 (59-81) .863
.484 11/2 9/1 .704
.100 58 (33-87) 52 (28-100) .550
.002 5 (38%) 4 (40%) .942
.175 1 (8%) 5 (50%) .025
.474 0 3 (30%) .038
.058 2 (15%) 0 .194
aortic aneurysm
P value
Inflammatory AAA
P value
IgG4-related Non-IgG4-related
(n  13) (n  10)
0.463 7 (54%) 7 (70%) .442
0.359 2 (15%) 4 (40%) .192
0.986 3 (23%) 5 (50%) .189
0.075 1 (8%) 1 (10%) .849
0.991 3 (23%) 1 (10%) .412
0.027 7 (54%) 1 (10%) .025
0.171 5 (38%) 1 (10%) .123
0.102 4 (31%) 1 (10%) .232rotic
atory
3)
1)
00)
)
)
)inalsurgery.
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ination are shown in Table III. The WBC and CRP in
patients with IAAA were significantly higher than those
with aAAA. Serum total protein and albumin were lower in
IAAA patients statistically. ANA was more frequently de-
tected in IAAA cases. In particular, high titers of ANA
(more than 320) were detected in two cases (40%) of
IgG4-related IAAA, whereas the titer of ANA was low
(0-80) in patients with aAAA or non-IgG4-IAAA, except
one. Comparing patients with IgG4-IAAA and non-IgG4-
IAAA cases, only serum IgG4 and IgE levels were signifi-
cantly different. Serum IgG4 concentrations were signifi-
cantly elevated in patients with IgG4-IAAA (average, 274;
range, 109-559; normal range, 110 mg/dL) compared
to non-IgG4-IAAA (average, 23; range, 8-36). Interest-
ingly, serum IgE concentrations were also elevated in all
patients with IgG4-IAAA (average, 1124 IU/mL; range,
242-2300; normal range, 200), but not in any cases of
non-IgG4-IAAA (average, 27; range, 3-78). Serum con-
centrations of other immunoglobulins, C3 and C4 comple-
ments, lipid factors, and the functional markers of the liver
and kidney were not different among the three groups.
Pathological findings. Pathological findings are sum-
marized in Table IV. IAAA was pathologically character-
ized by marked fibrous thickening of the adventitia. Nota-
Table III. Laboratory findings of patients with abdomina
AAA
Atherosclerotic Infla
White blood cell
count (WBC) (/L) 5938  1854 836
C-reactive protein
(CRP) (mg/dL) 0.4  0.9 3
Total protein (g/dL) 6.9  0.6 6
Albumin (g/dL) 4.2  0.6 3
IgG* (mg/dL) 1403.8  407.1 1462
IgG4* (mg/dL) 36.9  23.9 173
IgA* (mg/dL) 338.8  254.8 335
IgM* (mg/dL) 94.3  64.5 94
IgE* (IU/mL) 212.5  51.7 685
Antinuclear antibody* (40 titers) 2 (4% of cases) 4 (40
Antinuclear antibody* (320 titers) 1 (2% of cases) 2 (20
C3* (mg/dL) 141.8  29.9 142
C4* (mg/dL) 32.5  9.4 32
Total cholesterol (mg/dL) 180.9  34.8 173
HDL cholesterol (mg/dL) 40.3  9.5 48
LDL cholesterol (mg/dL) 100.9  29.3 98
Triglyceride (mg/dL) 126.9  63.1 96
AST (IU/L) 23.4  13.0 40
ALT (IU/L) 18.4  12.5 29
	-GTP (IU/L) 36.7  49.9 45
ALP (IU/L) 252  108.7 28
PT INR 1.16  0.17 1.2
Blood urea nitrogen (mg/dL) 20.3  11.5 18
Creatinine (mg/dL) 1.2  1.1 1
AAA, Abdominal aortic aneurysm;HDL, high-density lipoprotein; LDL, lo
ferase; 	-GTP, 	-glutamyl transpeptidase; ALP, alkaline phosphatase; PT, p
*Preoperative serum samples were available in 6 cases of IgG4-related infla
atherosclerotic AAA.bly, IgG4-IAAA showed significantly thicker adventitiathan non-IgG4-IAAA (P  .033). In the adventitia of
inflammatory cases, diffuse lymphoplasmacytic infiltration
was observed and it was associated with storiform fibrosis.
Of 13 cases of IgG4-IAAA, 12 had obliterative phlebitis,
which is one of the characteristic pathologic findings of
IgG4-SD in the adventitia. In addition, as mentioned in
our previous study,22 IgG4-IAAA was characterized by the
frequent infiltration of eosinophils, lymphoid follicle for-
mation, perineural inflammatory extension, and inconspic-
uous infiltration of neutrophils compared to non-IgG4-
IAAA. Atherosclerotic intimal thickening with or without
calcification was a characteristic feature of aAAA, and it was
more conspicuous in non-IgG4-IAAA than in IgG4-IAAA
(P  .012). Immunostaining of IgG4 revealed diffuse
infiltration of IgG4-positive plasma cells in the adventitia in
IgG4-IAAA. The number of IgG4-positive plasma cells and
the ratio of IgG4/IgG-positive plasma cells were signifi-
cantly higher in IgG4-IAAA than in aAAA or non-IgG4-
IAAA.
Intraoperative findings. All patients underwent graft
replacement surgical procedures. The surgeons identified
the characteristic white glistening perianeurysmal fibrosis in
seven cases (30%) of IAAA but in no aAAA (P  .001). In
our impression, no clear differences between IgG4-IAAA
and non-IgG4-IAAA were apparent in macroscopic find-
ic aneurysm
P-value
Inflammatory AAA
P-valuetory IgG4-related Non-IgG4-related
3818 < .001 8739  2689 7890  5054 .609
2.2 < .001 2.6  2.2 3.8  2.2 .485
0.8 .023 6.6  0.7 6.4  0.9 .469
0.9 < .001 3.4  0.9 3.3  0.9 .789
369.9 .680 1474.8  295.1 1444.3  514.6 .907
92.9 < .001 273.5  91.6 22.8  13.4 .034
128.8 .969 333.3  134.1 339.3  140.7 .945
79.6 .991 110.0  34.7 70.0  55.4 .469
867.4 .029 1124.3  881.9 27.1  12.9 .041
cases) .039 3 (50% of cases) 1 (25% of cases) .303
cases) .019 2 (33% of cases) 0 .023
43.4 .940 138.5  45.0 148.8  46.8 .738
7.2 .988 34.8  8.3 28.9  3.6 .225
45.2 .484 157.5  42.9 194.4  41.2 .618
9.8 .800 48.3  11.3 48.3  7.2 .161
22.1 .814 96.3  23.5 102.7  22.9 .713
42.1 .073 83.1  36.8 118.7  43.1 .079
54.8 .064 46.3  71.1 32.8  22.2 .578
29.9 .042 30.2  36.1 28.7  21.1 .91
45.2 .487 46.6  52.4 48.00  36.4 .834
163 .306 301  194 269  119 .653
0.31 .383 1.19  0.18 1.26  0.43 .622
7.5 .511 17.5  5.7 19.7  9.6 .503
0.6 .079 1.0  0.4 1.3  0.8 .276
sity lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotrans-
mbin time.
ory AAA, 4 cases of non-IgG4 related inflammatory AAA, and all cases ofl aort
mma
9 
.1 
.5 
.3 
.6 
.2 
.5 
.0 
.4 
% of
% of
.6 
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.3 
.3 
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.9 
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7 
2 
.5 
.1 
w-den
rothro
mmatings. At the time of surgery, perianeurysmal fibrosis was
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non-IgG4-IAAA (4 cases, 31%), while tighter adhesion to
surrounding structures of the abdominal aorta (duodenum
and retroperitoneum) was noted in two cases of IgG4-
IAAA.
Postoperative outcome. Two patients (15%) with
IgG4-IAAA died within 30 days after surgery. One patient
died of duodenal rupture and acute peritonitis on the third
postoperative day, probably due to tight fibrous adhesion
of abdominal aorta and the duodenum. The other patient
was complicated with bronchial pneumonia and infective
seroma in the lateral abdomen after surgery. This patient
died of candida infection on the twentieth postoperative
day. In contrast, all patients with aAAA and non-IgG4-
IAAA were alive 30 days after surgery. No differences with
regard to perioperative complications or reoperation were
found among the three groups.
DISCUSSION
In this study, we examined the clinical characteristics of
IgG4-IAAA. The obtained results could be summarized as
follows: (1) IgG4-IAAA is 5% of total surgical AAA cases,
and 57% of IAAA. (2) Aneurysmal rupture in IgG4-IAAA
was less frequent than that in non-IgG4-IAAA. (3) Patients
with IgG4-IAAA were associated with allergic or autoim-
mune disorders. (4) Serum IgG4 and IgE concentrations
and ANA (320 titers) were useful for discriminating
between IgG4-IAAA and non-IgG4-IAAA. (5) As de-
scribed in our previous study,22 IgG4-IAAA is pathologi-
cally characterized by adventitial thickening with numerous
IgG4-positive plasma cell infiltration and obliterative phle-
bitis.
It is surprising that 5% of surgical AAA cases were
IgG4-IAAA. Before starting this study, we speculated that
IgG4-IAAA was not a common disorder; however, this
study revealed that more than half of IAAA cases were
IgG4-related. The precise incidence of IgG4-related cases
in AAA, including non-surgical cases, is still unknown, but
Table IV. Pathological findings of atherosclerotic and infl
AAA
Atherosclerotic Inflam
(n  40) (n
Adventitial thickening (mm) 0.46  0.34 4.91
Intimal thickening (mm) 2.3  1.0 1.4
IgG cells (/hpf) 62.7  52.1 95.8
IgG4 cells (/hpf) 9.5  6.2 55.2
IgG4/IgG cell ratio (%) 10.4  13.8 51.3
Neutrophils (10/hpf) 23 (58%) 8
Eosinophils (5/hpf) 0 12
Plasma cells (10/hpf) 14 (35%) 19
Lymphoid follicle 4 (10%) 19
Obliterative phlebitis 1 (3%) 16
Perineural inflammation 2 (5%) 15
AAA, Abdominal aortic aneurysm; hpf, high-power fieldtesting serum IgG4 concentrations could be a useful non-invasive method to diagnose IgG4-IAAA, as for other
IgG4-SD.
IgG4-SD has similar clinical characteristics irrespective
of the organ of origin.13-22 The most important clinical
characteristic is steroid sensitivity. IgG4-SD usually mani-
fests as pseudo-tumorous swelling of the affected organ,
and some have been called inflammatory pseudotu-
mor.14,18,24 IgG4-SD dramatically responds to steroid
therapy for 2 or 3 weeks.20 It is an important issue whether
or not steroid therapy is useful for IgG4-IAAA, as for other
organs. In this study, no patients were examined to treat by
steroids, although it is speculated that adventitial thicken-
ing could be reduced by steroid therapy. Preoperative
steroid therapy might be useful to reduce retroperitoneal
fibrous adhesion, which could reduce the surgical risk;
however, the risk of aneurysmal rupture might be elevated
by thinning the adventitia. The balance between reducing
retroperitoneal adhesion and the risk of rupture seems
important. Further investigations are mandatory to con-
clude how we should use steroids during the medical
management of IgG4-IAAA.
At surgery, owing to dense fibrous adherence to the
surrounding structures of the abdominal aorta, IAAA
makes dissection difficult, and inadvertent entry may lead
to fatal complications.4 The mortality rate in aAAA was
reported 3-4%.2 Among the three groups, only the sub-
group of patients with IgG4-IAAA (2 cases) died within 30
days after surgery with a high mortality rate (15%), proba-
bly because tighter fibrous adhesion in IgG4-IAAA causes
more surgical difficulties. We expected that an endovascular
approach together with steroid therapy would be appropri-
ate management for IgG4-IAAA.
Before now, the interpretation of IAAA was controver-
sial. IAAA was estimated as an extreme end of aAAA by
some investigators,5-7 whereas others suggested an autoim-
mune or infectious pathogenetic process in IAAA.8-12 We
pathologically examined IAAA with regard to IgG4-SD,
and concluded that IAAA could be classified into two types:
atory abdominal aortic aneurysm
P value
Inflammatory AAA
P value
ory IgG4-related Non-IgG4-related
(n  13) (n  10)
6 < .001 5.58  1.56 4.11  1.45 .033
.003 1.04  0.61 1.99  0.96 .012
.4 .011 110.2  35.4 78.6  33.6 .046
.8 < .001 88.5  32.13 15.3  13.2 < .001
.8 < .001 80.2  3.2 17.6  4.5 < .001
) .083 1 (8%) 7 (70%) .002
) < .001 11 (85%) 1 (10%) .001
) < .001 13 (100%) 6 (60%) .012
) < .001 13 (100%) 3 (30%) < .001
) < .001 12 (92%) 4 (40%) .002
) < .001 12 (92%) 3 (30%) .002amm
mat
 23)
 1.6
 0.9
 37
 44
 38
(35%
(52%
(83%
(83%
(70%
(65%IgG4-related and non-related cases.22 We speculate that
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related immune reaction, and could be one of the manifes-
tations of IgG4-SD. It seems important to clearly discrim-
inate between IgG4-related or non-related cases among
IAAAs, because those two conditions have different clini-
copathological characteristics. In particular, the risk of an-
eurysmal rupture or steroid sensitivity might be different
between them.
Interestingly, patients with IgG4-IAAA were fre-
quently complicated with allergic disorders, such as bron-
chial asthma or drug allergy. In addition, serum IgE con-
centration was significantly elevated in IgG4-related cases.
The detailed immune reaction in IgG4-SD is still contro-
versial, and the mechanisms of IgG4-positive plasma cell
infiltration and elevation of serum IgG4 concentrations
have not been elucidated so far; however, the relationship
between IgG4-SD and allergy-like immune reactions has
attracted much attention.23 Recently, we performed a
study on cytokine production in situ in IgG4-SD.25 It was
revealed that the expression of Th2 (IL-4, IL-5, IL-13) and
regulatory cytokines (transforming growth factor [TGF]-

and IL-10) was increased in IgG4-SD.25 Th2-dominate
immune reactions observed in IgG4-SD were different
from most autoimmune diseases, which are usually charac-
terized by a Th1-dominate reaction,26,27 and rather resem-
bled allergic immune reaction.28 In addition, we speculated
that IL-10 might participate in increasing serum IgG4 con-
centrations and IgG4-positive plasma cell infiltration, because
IL-10 has a potent function in directing B cells to produce
IgG4.29,30 TGF-
, which is a powerful fibrogenic cytokine,
might participate in fibroplasia.31 Immune reactions in IAAA
are still an enigma, although Th2 or regulatory immune
reactionsmight be increased in the aneurysmwall or periaortic
soft tissue. These unique immune reactions might induce the
elevation of serum IgG4 and IgE concentration in patients
with IgG4-IAAA.
We revealed an association with autoimmunity in
IgG4-IAAA, that is, a significantly higher incidence of
autoimmune diseases and frequent presence of ANA, com-
pared to two other groups of AAA. Especially in two patients
with IgG4-IAAA, the titer of ANA was so high (more than
320). Although ANA positivity was detected in non-IgG4-
IAAA, the titer of ANA was low (40-80) and would be
nonspecific. Autoantibodies including ANA and rheumatoid
factor were also frequently observed in IgG4-SD.20,21 There-
fore, the significance of the high titer of ANA is also a useful
laboratory sign in screening for IgG4-IAAA.
We found non-IgG4-IAAA had some clinicopatholog-
ical resemblance to aAAA. Indeed Rose and Dent6 ex-
plained that IAAAwas the extreme end of the inflammatory
process of aAAA, because of no sharp distinction between
aAAA and IAAA. However, considering the autoimmune
aspects of non-IgG4-IAAA, we approved of other hypoth-
eses such as autoimmune reactions against the local anti-
gens, such as oxidized low-density lipoproteins and cer-
oid in atherosclerotic plaque.10 Through highly
destructed intima and media of the aortic wall, the
long-term leakage of serum-unknown antigens would beinvolved in chronic inflammation. Another possible
causal factor was chronic continuous infections in the
aortic wall, for instance, Chlamydia pneumonia and Cy-
tomegalovirus.11,12 Under recognition of the different
subgroups of IAAA, further studies are needed to reveal
the pathogenesis of non-IgG4-IAAA.
In conclusion, the present study revealed that IgG4-
IAAA is not so rare. It seems important to precisely diag-
nose IgG4-IAAA, because the clinicopathological charac-
teristics of those patients were different from those with
aAAA and non-IgG4-IAAA.
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Elevated serum immunoglobulin-G4 (IgG4) has been
linked to several overlapping syndromes that are related to
IgG4-producing plasma cells. These clinical syndromes include
cholangitis, autoimmune hepatitis and pancreatitis, Sjögren’s syn-
drome, nephritis, and retroperitoneal fibrosis, and the spectrum of
this disease has been labeled “IgG4-related systemic disease.”
Management of IgG4-related systemic disease generally includes
immunosuppressive therapy; dramatic responses to medical ther-
apy have obviated surgical management in many cases.
Inflammatory aneurysms have long proved to be challenging
for vascular surgeons, with chronic periaortitis, inflammation, and
fibrosis increasing the difficulty of surgical repair, and, possibly
paradoxically, reducing the risk of rupture. The authors have
previously published their examination of a small series (n 10) of
inflammatory aneurysms, and showed that four of the 10 inflam-
matory aneurysms had abundant IgG4-positive plasma cells and
histological changes typical of IgG4-related systemic disease. In
this paper, the authors expand their examination to the 23 cases of
inflammatory aneurysms that were treated over 12 years, 13 cases
of which contained IgG4-positive plasma cells. These patients were
associated with reduced risk of rupture, other allergic or autoim-
mune disorders, and positive serology for IgG4, IgE, and anti-
nuclear antibody (ANA), compared with the 10 cases that did not
contain IgG4-positive plasma cells.
The implications of this report suggest that IgG4-related
inflammatory aneurysms may be treated medically, rather than
surgically; conversely, the high rate of rupture in IgG4-negativeranted. Optimal medical and surveillance strategies need to be
defined for IgG4-related aneurysms, and optimal surgical strate-
gies, that minimize complication risk, need to be defined for
IgG4-negative aneurysms. As the only other report of IgG4-
related inflammatory aneurysm disease has come from another
Japanese group,1 the utility of these observations will be clari-
fied as they are extended to other populations.
There are implications for other vascular diseases as well. For
example, Kawasaki disease is an acute inflammatory childhood
vasculitis with intense secretion of cytokines that permanently
damage the vascular endothelium and typically result in coronary
aneurysms. This disease is usually treated with immune globulin
and aspirin, with steroid therapy being controversial. Should Ka-
wasaki disease prove to be IgG4-related, then additional insights
into its management will be obtained.
Ultimately, the increasing importance of the role of the im-
mune system in the pathogenesis of atherosclerosis is being recog-
nized. If IgG4-related systemic disease plays a causative role in the
formation of atherosclerosis in even a small subset of patients,
medical therapy for this important vascular disease may ultimately
prove to be a reality.
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